Skip to main content
. 2019 Jun 6;6(7):ofz273. doi: 10.1093/ofid/ofz273

Table 1.

Minimum Inhibitory Concentrations for β-Lactams and β-Lactam/β-Lactam Inhibitor Combinations

MIC (µg/mL)
Strain AMP ATM FEP CZAa C/T MEM CZA + ATMb MEM + VABc ATM + VABc
PA_HTX1 ND >256 >256 128 >256 >32 8 >32 >256
PA_HTX2 ND >256 >16 >256 >256 >32 4 >32 >256
TG1 + pBA169 3 0.032 0.064 0.25 0.064 0.016 ND ND ND
TG1 + pBA169::blaGES-19 >256 1.5 1 4 0.125 0.012 ND ND ND
TG1 + pBA169::blaGES-26 >256 0.25 0.5 2 0.38 0.016 ND ND ND
TG1 + pBA169::blaGES-19–26 >256 >256 >256 >256 48 2 2 ND 0.25
TG1 + pBA169::blaOXA-2 >256 0.094 0.5 0.125 0.125 0.064 ND ND ND

Abbreviations: AMP, ampicillin; ATM, aztreonam; C/T, ceftolozane/tazobactam; CZA, ceftazidime/avibactam; FEP, cefepime; MEM, meropenem; MIC, minimum inhibitory concentration; ND, not done; VAB, vaborbactam.

aPerformed by broth microdilution, all others performed by E-test.

bAvibactam 2.2 µg/mL, to mimic the mean steady-state nadir in human plasma.

cVaborbactam 2 µg/mL, to mimic the mean steady-state nadir in human plasma.